G. L. Armstrong, A. Wasley, E. P. Simard, G. M. Mcquillan, W. L. Kuhnert et al., The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002, Annals of Internal Medicine, vol.144, issue.10, pp.705-714, 1999.
DOI : 10.7326/0003-4819-144-10-200605160-00004

M. Aus-dem-siepen, V. Lohmann, M. Wiese, S. Ross, M. Roggendorf et al., Nonstructural protein 5A does not contribute to the resistance of hepatitis C virus replication to interferon alpha in cell culture, Virology, vol.336, issue.2, pp.131-136, 2005.
DOI : 10.1016/j.virol.2005.03.012

K. J. Blight, J. A. Mckeating, and C. M. Rice, Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication, Journal of Virology, vol.76, issue.24, pp.13001-13014, 2002.
DOI : 10.1128/JVI.76.24.13001-13014.2002
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC136668

R. Brillet, F. Penin, C. Hezode, P. Chouteau, D. Dhumeaux et al., The Nonstructural 5A Protein of Hepatitis C Virus Genotype 1b Does Not Contain an Interferon Sensitivity???Determining Region, The Journal of Infectious Diseases, vol.195, issue.3, pp.432-441, 2007.
DOI : 10.1086/510316

R. Burioni, P. Plaisant, A. Manzin, D. Rosa, V. Delli-carri et al., Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant fab fragments, Hepatology, vol.68, issue.3, pp.810-814, 1998.
DOI : 10.1002/hep.510280331

N. A. Cannon, M. J. Donlin, X. Fan, R. Aurora, and J. E. Tavis, Hepatitis C Virus Diversity and Evolution in the Full Open-Reading Frame during Antiviral Therapy, PLoS ONE, vol.8, issue.5, 2008.
DOI : 10.1371/journal.pone.0002123.s002

J. M. Cuevas, M. Torres-puente, N. Jimenez-hernandez, M. A. Bracho, I. Garcia-robles et al., Genetic Variability of Hepatitis C Virus before and after Combined Therapy of Interferon plus Ribavirin, PLoS ONE, vol.87, issue.8, p.3058, 2008.
DOI : 10.1371/journal.pone.0003058.s010

D. T. Dieterich, M. Rizzetto, and M. P. Manns, Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin, Journal of Viral Hepatitis, vol.46, issue.4, pp.833-843, 2009.
DOI : 10.1111/j.1365-2893.2009.01218.x

A. El-shamy, M. Nagano-fujii, N. Sasase, S. Imoto, S. R. Kim et al., Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy, Hepatology, vol.88, issue.Pt 3, pp.38-47, 2008.
DOI : 10.1002/hep.22339

N. Enomoto, I. Sakuma, Y. Asahina, M. Kurosaki, T. Murakami et al., Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region., Journal of Clinical Investigation, vol.96, issue.1, pp.224-230, 1995.
DOI : 10.1172/JCI118025

J. J. Feld and J. H. Hoofnagle, Mechanism of action of interferon and ribavirin in treatment of hepatitis C, Nature, vol.128, issue.7053, pp.967-972, 2005.
DOI : 10.1126/science.1114016

G. Jr, M. J. Korth, M. J. Katze, and M. G. , Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance, Clin. Diagn. Virol, vol.10, pp.157-162, 1998.

B. Gao, F. Hong, and S. Radaeva, Host factors and failure of interferon-?? treatment in hepatitis C virus, Hepatology, vol.17, issue.4, pp.880-890, 2004.
DOI : 10.1002/hep.20139

C. Gaudy, M. Lambele, A. Moreau, P. Veillon, F. Lunel et al., Mutations within the Hepatitis C Virus Genotype 1b E2-PePHD Domain Do Not Correlate with Treatment Outcome, Journal of Clinical Microbiology, vol.43, issue.2, pp.750-754, 2005.
DOI : 10.1128/JCM.43.2.750-754.2005

D. Ge, J. Fellay, A. J. Thompson, J. S. Simon, K. V. Shianna et al., Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance, Nature, vol.18, issue.7262, pp.399-401, 2009.
DOI : 10.1038/nature08309

M. G. Ghany, D. B. Strader, D. L. Thomas, and L. B. Seeff, Diagnosis, management, and treatment of hepatitis C: An update, Hepatology, vol.11, issue.Suppl 5, pp.1335-1374, 2009.
DOI : 10.1002/hep.22759

T. A. Hall, BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95, Nucleic Acids Symp, pp.95-98, 1999.

M. K. Jain, H. J. Yuan, B. Adams-huet, A. Reeck, J. Shelton et al., Pegylated Interferon and Ribavirin Promote Early Evolution of Nonstructural 5A Protein in Individuals with Hepatitis C Who Demonstrate a Response to Treatment, The Journal of Infectious Diseases, vol.200, issue.6, pp.866-876, 2009.
DOI : 10.1086/605475

A. C. Jardim, L. H. Yamasaki, A. T. De-queiroz, C. Bittar, J. R. Pinho et al., Quasispecies of hepatitis C virus genotype 1 and treatment outcome with Peginterferon and Ribavirin???, Infection, Genetics and Evolution, vol.9, issue.4, pp.689-698, 2009.
DOI : 10.1016/j.meegid.2008.11.001

C. T. Jones, C. L. Murray, D. K. Eastman, J. Tassello, and C. M. Rice, Hepatitis C Virus p7 and NS2 Proteins Are Essential for Production of Infectious Virus, Journal of Virology, vol.81, issue.16, pp.8374-8383, 2007.
DOI : 10.1128/JVI.00690-07

B. Korber, HIV Signature and Sequence Variation Analysis. Computational Analysis of HIV Molecular Sequences, 2000.

T. Kuntzen, J. Timm, A. Berical, L. L. Lewis-ximenez, A. Jones et al., Viral Sequence Evolution in Acute Hepatitis C Virus Infection, Journal of Virology, vol.81, issue.21, pp.11658-11668, 2007.
DOI : 10.1128/JVI.00995-07
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2168804

L. Jr, G. H. Korber, B. T. Foley, B. Hahn, B. H. Wolinsky et al., Maintaining the integrity of human immunodeficiency virus sequence databases, J. Virol, vol.70, pp.5720-5730, 1996.

N. Leone and M. Rizzetto, Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma, Minerva Gastroenterol . Dietol, vol.51, pp.31-46, 2005.

V. Lohmann, F. Korner, J. Koch, U. Herian, L. Theilmann et al., Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line, Science, vol.285, issue.5424, pp.110-113, 1999.
DOI : 10.1126/science.285.5424.110

L. Lu, T. Nakano, Y. He, Y. Fu, C. H. Hagedorn et al., Hepatitis C virus genotype distribution in China: Predominance of closely related subtype 1b isolates and existence of new genotype 6 variants, Journal of Medical Virology, vol.22, issue.4, pp.538-549, 2005.
DOI : 10.1002/jmv.20307

P. Marcellin, Hepatitis C: the clinical spectrum of the disease, Journal of Hepatology, vol.31, pp.31-40, 1999.
DOI : 10.1016/S0168-8278(99)80368-7

J. G. Mchutchison, E. J. Lawitz, M. L. Shiffman, A. J. Muir, G. W. Galler et al., Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection, New England Journal of Medicine, vol.361, issue.6, pp.580-593, 2009.
DOI : 10.1056/NEJMoa0808010

J. M. Pawlotsky, Treating Hepatitis C in ???Difficult-to-Treat??? Patients, New England Journal of Medicine, vol.351, issue.5, pp.422-423, 2004.
DOI : 10.1056/NEJMp048068

T. Phan, R. K. Beran, C. Peters, I. C. Lorenz, and B. D. Lindenbach, Hepatitis C Virus NS2 Protein Contributes to Virus Particle Assembly via Opposing Epistatic Interactions with the E1-E2 Glycoprotein and NS3-NS4A Enzyme Complexes, Journal of Virology, vol.83, issue.17, pp.8379-8395, 2009.
DOI : 10.1128/JVI.00891-09

A. Sakai, M. S. Claire, K. Faulk, S. Govindarajan, S. U. Emerson et al., The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences, Proceedings of the National Academy of Sciences, vol.100, issue.20, pp.11646-11651, 2003.
DOI : 10.1073/pnas.1834545100

M. Sarasin-filipowicz, E. J. Oakeley, F. H. Duong, V. Christen, L. Terracciano et al., Interferon signaling and treatment outcome in chronic hepatitis C, Proceedings of the National Academy of Sciences, vol.105, issue.19, pp.7034-7039, 2008.
DOI : 10.1073/pnas.0707882105

E. Steinmann, F. Penin, S. Kallis, A. H. Patel, R. Bartenschlager et al., Hepatitis C Virus p7 Protein Is Crucial for Assembly and Release of Infectious Virions, PLoS Pathogens, vol.22, issue.7, p.103, 2007.
DOI : 10.1371/journal.ppat.0030103.sg001

C. Stgelais, T. L. Foster, M. Verow, E. Atkins, C. W. Fishwick et al., Determinants of Hepatitis C Virus p7 Ion Channel Function and Drug Sensitivity Identified In Vitro, Journal of Virology, vol.83, issue.16, pp.7970-7981, 2009.
DOI : 10.1128/JVI.00521-09

V. Suppiah, M. Moldovan, G. Ahlenstiel, T. Berg, M. Weltman et al., IL28B is associated with response to chronic hepatitis C interferon-?? and ribavirin therapy, Nature Genetics, vol.81, issue.10, pp.1100-1104, 2009.
DOI : 10.1038/ng.447

T. Sy and M. M. Jamal, Epidemiology of Hepatitis C Virus (HCV) Infection, International Journal of Medical Sciences, vol.3, pp.41-46, 2006.
DOI : 10.7150/ijms.3.41

Y. Tanaka, N. Nishida, M. Sugiyama, M. Kurosaki, K. Matsuura et al., Genome-wide association of IL28B with response to pegylated interferon-?? and ribavirin therapy for chronic hepatitis C, Nature Genetics, vol.131, issue.10, pp.1105-1109, 2009.
DOI : 10.1038/ng.449

M. Troesch, I. Meunier, P. Lapierre, N. Lapointe, F. Alvarez et al., Study of a novel hypervariable region in hepatitis C virus (HCV) E2 envelope glycoprotein, Virology, vol.352, issue.2, pp.357-367, 2006.
DOI : 10.1016/j.virol.2006.05.015

Y. H. Tsai, W. F. Kuang, T. Y. Lu, J. H. Kao, M. Y. Lai et al., The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism, Journal of Hepatology, vol.49, issue.6, pp.899-907, 2008.
DOI : 10.1016/j.jhep.2008.06.030

A. Wohnsland, W. P. Hofmann, and C. Sarrazin, Viral Determinants of Resistance to Treatment in Patients with Hepatitis C, Clinical Microbiology Reviews, vol.20, issue.1, pp.23-38, 2007.
DOI : 10.1128/CMR.00010-06

G. L. Xia, C. B. Liu, H. L. Cao, S. L. Bi, M. Y. Zhan et al., Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992, International Hepatology Communications, vol.5, issue.1, pp.62-73, 1992.
DOI : 10.1016/S0928-4346(96)82012-3

Z. Xu, X. Fan, Y. Xu, D. Bisceglie, and A. M. , Comparative Analysis of Nearly Full-Length Hepatitis C Virus Quasispecies from Patients Experiencing Viral Breakthrough during Antiviral Therapy: Clustered Mutations in Three Functional Genes, E2, NS2, and NS5a, Journal of Virology, vol.82, issue.19, pp.9417-9424, 2008.
DOI : 10.1128/JVI.00896-08

E. Yao and J. E. Tavis, A general method for nested RT-PCR amplification and sequencing the complete HCV genotype 1 open reading frame, Virology Journal, vol.2, issue.1, p.88, 2005.
DOI : 10.1186/1743-422X-2-88

J. Zhong, P. Gastaminza, G. Cheng, S. Kapadia, T. Kato et al., Robust hepatitis C virus infection in vitro, Proceedings of the National Academy of Sciences, vol.102, issue.26, pp.9294-9299, 2005.
DOI : 10.1073/pnas.0503596102